Skip to content

RVMD

Revolution Medicines, Inc.

Stock

$205.26+0.78 (+0.38%)Close Sep 30, 2026

EBITDA (TTM)−$1.6B

EBITDA

PeriodEBITDAYoY
2025−$1.2B—
2024−$683M—
2023−$482M—
2022−$254M—
2021−$185M—
2020−$108M—
2019−$52M—
2018−$39M—